Chinese healthcare market for drugs accounts for 1.4 billion populations.
Chinese Clinical Imported and Overseas New Drugs - Guidebook for Review and Approval Procedures Chinas 1.3 billion has been routed as the second largest economy in the global domain, with an increase in the dominance of the global economy. The country has been one of the largest in contributing to the worldwide growth in the financial crisis of 2008. China is one of the fastest growing global economies with a one-fifth population in the world. Nowadays, China has become the worlds second largest healthcare market after the United States. Facing a gigantic population and rapid population aging, the Chinese government accelerated the priority approval of innovative drugs and relaxed the market access for overseas drugs to cope with the clinical urgent demand. In recent years, China’s fast-track approval time is much shorter than any other country, which attracts more and more overseas pharmaceutical manufacturers to enter into the Chinese healthcare market. Undoubtedly the Chi...